The MT Conferences section did not involve the reporting or the editorial staff of The Moscow Times.
Irina Naumenko
Head of Pharmaceutical Group
Pepeliaev Group
Medical devices in Russia are feeling the heat from the state's interest in the industry. This interest has not only resulted in a series of new regulations passed over the last few months, but also several very exciting drafts now under discussion.
Particularly notable is the government's decree dated Dec. 27, 2012 No. 1416 On Approval of the Rules of Medical Devices Registration. The Decree has been in force since Jan. 1, 2013, and requires all registration certificates to be changed. Those that run for a fixed term must be changed by the end of that term, while for those that run for an indefinite term there is a deadline of Jan. 1, 2014 for making the changes.
Meanwhile, if the type of a medical device cannot be stated because the relevant classification has not yet been developed, the result is a number of free spaces in the application form to amend a registration certificate and also in the form for a new registration certificate. This suggests that certificates will have to be renewed so that all the free spaces can be completed. The question is how long the market participants will be able to manage with the "new" registration certificates that do not include all the information required for public procurement tenders. It seems that the "new" certificates have to be changed again as soon as the relevant classification is approved.
The resolution has left behind all the issues with the package that contained information about the "old" certificate, and the transitional period for renewing licenses and conformity certificates. All these issues are vital for the safety and consistency of business, but ignoring them, as the decree has done, has created many headaches for market players that cannot be resolved in practice without state authorities issuing relevant guidelines.
Moreover, a very interesting comment has been circulating about the renewal of registration certificates on medical devices that were registered in 1996-1997. At that time, it was the Health Ministry that handled the registration of medical devices. Unfortunately, the dossiers were not transferred from the ministry to Roszdravnadzor, the regulatory body that is now responsible for matters relating to medical devices. The relevant clause of the decree prohibits additional documents from being demanded for the purposes of registration or amending a registration certificate if the documents are not listed in the decree. Nevertheless, Roszdravnadzor does not have all the dossiers for medical devices so it cannot match applications against them. For this reason, Roszdravnadzor is trying to obtain the dossiers from applicants, though it is hardly likely to make such a request official.
Another widely discussed topic is the draft decree that imposes restrictions on the supply of medical devices for state procurement. The draft was prepared by the Russian Ministry of Industry and Trade with a view to establishing a rule under which all publicly financed state procurement transactions should be made only for the supply of medical devices originating from Russia or Belarus. It is implied that a list will be developed of medical devices to which the above rule is to apply. Unfortunately, there is no draft of the list as available and nor is there any general understanding of the concept behind its creation. Logically, the list should include medical devices that are produced in Russia at least by two manufacturers, so that a minimum level of competition is at least preserved, but no one knows how this is supposed to be achieved.
All foreign manufacturers of medical devices, as well as some domestic Russian manufacturers, have expressed their concern over the draft and its potential implementation. This happened during a meeting that was organized by the Federal Anti-Monopoly Service on Jan. 23, 2013 to discuss the draft. The aim behind the draft is to encourage manufacturers of medical devices to localize their production in Russia. The chosen method is very questionable as previously, in other sectors, the drive to localize manufacturing was achieved through significant customs and tax payments being granted to producers, as well as contract guarantees being given of stable demand for the localized product (as in the automobile industry or energy engineering industry). It is not clear why of the preferences approach has been jettisoned for medical devices. All market players are hoping that the approach will be switched from restrictions to preferences.
One can only hope that manufacturers of medical devices will have sufficient patience and assets to survive during this time of changes.
The MT Conferences section did not involve the reporting or the editorial staff of The Moscow Times.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
